Comparing two heart failure medications in ICD patients
Treatments studied
Part of Heart & circulation clinical trials.
This trial compares two beta-blocker medications, carvedilol and metoprolol succinate, to see which one works better for people with heart failure who have an implantable cardioverter defibrillator (ICD). If you are currently taking metoprolol succinate, you may be able to switch to carvedilol and help researchers find the best treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have an ICD placed to prevent sudden cardiac arrest due to heart failure, and it has remote monitoring.
- You are currently taking metoprolol succinate for heart failure and are willing to switch to carvedilol.
- Your heart's pumping ability (LVEF) has been below 50% in the last 12 months.
- You have not had a bad reaction to carvedilol before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether the heart medication metoprolol can help people who have both heart failure with reduced pumping function and COPD (a lung condition). It aims to see if the drug is safe and effective for this combination of conditions.
This study compares modern heart failure medications and implantable cardioverter-defibrillators (ICDs) to reduce the risk of sudden cardiac death in people with a specific type of heart muscle disease (non-ischemic cardiomyopathy) that is not caused by blocked arteries. It may help guide treatment decisions for those with a weakened heart and certain scarring on heart MRI.
This trial compares two types of “left-side” heart pacing to see which one works better in people with weak heart pumping. It may help guide the best pacing choice for improving heart function and symptoms.
This study compares two heart medicines, carvedilol and metoprolol succinate, for people with a certain type of heart failure. It aims to see if they work just as well as each other.
This trial tests whether starting the heart failure medication carvedilol early, along with standard monitoring, can help people in cardiogenic shock (when the heart can't pump enough blood) due to a weak heart muscle. It aims to see if earlier treatment improves outcomes.
This study tests a personalized approach to safely increase the dose of your heart failure medication (beta-blocker). It aims to improve your symptoms and overall heart function by tailoring the dose to your specific needs.
Hear when a new Sudden Cardiac Death trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.